Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Aleafia Health Inc ALEAF

Aleafia Health Inc. is a Canada-based cannabis company. The Company offers cannabis products in Canada and destined for international markets, including Australia and Germany. The Company operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. It owns three licensed cannabis production facilities and... see more

GREY:ALEAF - Post Discussion

Aleafia Health Inc > $20 Million raised at $0.83 = BUY at $0.71 :)
View:
Post by 1hot-techwoman on Feb 23, 2021 10:09am

$20 Million raised at $0.83 = BUY at $0.71 :)

Aleafia Health Announces Increase to Bought Deal Offering of Units to $20 Million

Wednesday, February 17, 2021, 9:20 AM ET
 

Aleafia Health Announces Increase to Bought Deal Offering of Units to $20 Million

TORONTO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) ("Aleafia Health" or the "Company") is pleased to announce that it has agreed to increase the size of its previously announced "bought deal" offering of units led by Cantor Fitzgerald Canada Corporation as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters (together, the "Underwriters"), pursuant to which the Underwriters have agreed to purchase 24,000,000 units of the Company (the "Units"), on a "bought deal" basis pursuant to a short form prospectus offering, subject to all required regulatory approvals, at a price per Unit of $0.83 (the "Issue Price") for gross proceeds of $19,920,000 (the "Offering").
Comment by 1hot-techwoman on Feb 23, 2021 11:21am
I hope everyone is taking advantage :)
Comment by philip1 on Feb 23, 2021 3:06pm
Please don't infer to less experienced retail trading individuals that the stock will miraculously be 83 cents on March 9th.
Comment by Toweringmars on Feb 23, 2021 3:23pm
Huh?? Who said what now?
Comment by philip1 on Feb 23, 2021 3:25pm
i interpreted this comment as people should buy now
Comment by Toweringmars on Feb 23, 2021 4:03pm
If US retail is willing to buy at 0.83 its not a bad buy at 0.71... Its fine to have different opinions, but nobody was saying it would magically be 83 once the financing closed. Q4 and Q1 should be very telling as to where this is headed. Untill then we place our bets and secure our positions and battle it out.      
Comment by Francoic on Feb 23, 2021 5:11pm
Buy 2,000 shares at $ 0.83 = $ 1,660 + 1000 shares (2,000 options) at $ 1.05 = $ 1,050 Total = $ 2,710 for 3,000 shares, or approximately $ 0.90 per share   Considering the interest rates are extremely low, any purchase under $ 0.85 looks pretty good to me. Am I wrong ?
Comment by 1hot-techwoman on Feb 24, 2021 6:51am
Bingo :)
Comment by 1hot-techwoman on Feb 24, 2021 7:15am
Aleafia Health Announces Increase to Bought Deal Offering of Units to $20 Million Wednesday, February 17, 2021, 9:20 AM ET   Aleafia Health Announces Increase to Bought Deal Offering of Units to $20 Million TORONTO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) ("Aleafia Health" or the "Company") is pleased to announce that it ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities